摘要
冠心病为常见的心脏疾病之一,近年来发病率与病死率逐年上升,主要治疗方法之一为经皮冠状动脉介入治疗(PCI),取得不错的疗效,但术后再狭窄(ISR)依然是困扰患者的主要问题之一,本文通过查阅文献,对PCI术后再狭窄的病因病机、中医药治疗研究进展进行归纳总结,得出结论:本病的基本病机为"本虚标实",在虚的基础上化生气滞、血瘀、痰浊、毒邪等实邪,虚实夹杂,相间为病。临床上中医多采用中成药及中药汤剂治疗,常用药为丹参、黄芪、当归、川芎等;中成药虽方便携带,但不能精准对症;中药汤剂辨证施药,病位多以"心、脾、肾"为主,补益心气、调补脾胃、补肾助阳,在补虚的基础上活血化瘀通络等,达到祛邪的效果。
Coronary heart disease(CHD)is one of the common heart disease morbidity and mortality is also on the rise year by year in recent years,one of the main treatment method for percutaneous coronary intervention(PCI),and achieved good curative effect,but the postoperative restenosis(ISR)is still one of the major problems that affect sufferers,in this article,through the literature,the etiology and pathogenesis of PCI postoperative restenosis,the paper summarizes research progress of traditional Chinese medicine treatment,draw the conclusion:the disease of the basic pathogenesis of original virtual standard real,on the basis of virtual metaplasia and qi stagnation,blood stasis,phlegm turbidity and toxin factor such as evil,factors,and for the disease.In clinical practice,Chinese patent medicine and Chinese medicine decoction are used for treatment,and the common drugs are Salvia miltiorrhiza,astragalus,Angelica angelica and Ligusticum chuanxiong.Although Chinese patent medicine is convenient to carry,it can’t accurately identify the symptoms.TCM decoction is applied in differentiation of symptoms and signs,mainly in"heart,spleen and kidney",replenishing heart qi,regulating spleen and stomach,replenishing kidney and helping Yang,activating blood circulation,removing blood stasis and clearing collaterals on the basis of replenishing deficiency,so as to remove pathogenic factors.
作者
吕小茹
张景凤
LV Xiao-ru;ZHANG Jing-feng(Tianjin University of Traditional Chinese Medicine,Tianjin,300000;The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin,300000)
出处
《内蒙古中医药》
2021年第11期161-164,共4页
Inner Mongolia Journal of Traditional Chinese Medicine
关键词
冠心病PCI术后再狭窄
中医
研究进展
Restenosis of coronary heart disease after PCI
Traditional Chinese medicine
research progress
